Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.65
+1.05 (9.05%)
Aug 19, 2026, 9:54 AM EDT - Market open
Intellia Therapeutics Employees
Intellia Therapeutics had 377 employees as of December 31, 2025. The number of employees decreased by 26 or -6.45% compared to the previous year.
Employees
377
Change (1Y)
-26
Growth (1Y)
-6.45%
Revenue / Employee
$157,841
Profits / Employee
-$1,060,942
Market Cap
1.77B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 377 | -26 | -6.45% |
| Dec 31, 2024 | 403 | -123 | -23.38% |
| Dec 31, 2023 | 526 | -72 | -12.04% |
| Dec 31, 2022 | 598 | 113 | 23.30% |
| Dec 31, 2021 | 485 | 173 | 55.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Ascentage Pharma Group International | 767 |
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Xencor | 260 |
| Absci | 140 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
NTLA News
- 11 days ago - Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI - TheFly
- 12 days ago - Intellia Therapeutics upgraded to Outperform from In Line at Evercore ISI - TheFly
- 13 days ago - Intellia Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Intellia Therapeutics Earnings release: Q2 2026 - Filings
- 13 days ago - Intellia Therapeutics Quarterly report: Q2 2026 - Filings
- 13 days ago - Intellia Therapeutics reports Q2 EPS (80c), consensus (78c) - TheFly
- 13 days ago - Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire